Ovarian cancer is the most serious gynecological cancer. Endometrial cancer is the most common gynecological cancer. Diagnostic tools are insufficient. Screening markers are lacking. Chemotherapy resistance limits success of treatment.
Establishing novel diagnostic biomarkers is highly needed for ovarian and endometrial cancers.
Our research is focused on the search for them within circulating and cell-free microRNAs.
Many thanks belong to supporters of our oncological research in the Czech Republic:
Charles University in Prague